November 5, 2022

Apixaban shows more efficacy and safety than rivaroxaban in patients with atrial fibrillation and valvular heart disease

Among patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD), those treated with apixaban have achieved a lower rate of ischemic stroke or systemic embolism and a lower rate of intracranial or gastrointestinal bleeding than those treated with rivaroxaban. Researchers from a large retrospective study reported these findings on Oct 18, 2022 in the Annals of Internal Medicine. […]

admin Health 0 1 min read
September 29, 2022

Tenecteplase outperforms standard stroke treatment

Tenecteplase, a clot buster used off-label for treating ischemic stroke, outperforms alteplase, the standard treatment, in health outcomes and cost, researchers reported on September 23, 2022 in Stroke. Tenecteplase is administered in a single five- to 10-second intravenous injection. Alteplase is injected over a 60-minute period. “When it comes to treating patients with a stroke, every second matters,” said lead […]

admin Health 0 1 min read

Recent Posts

Meta

Categories

Archives

Recent Comments